Abstract
In our study we aimed to evaluate the effect of high-dose rosuvastatin (HIGH-RSV) versus low-dose rosuvastatin (LOW-RSV) on NLRP3 and Cathepsin B expression in peripheral blood monocytes in patients with acute coronary syndrome (ACS). Our study one hundred and twenty three subjects (123 subjects)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
